AbbVie Inc.


Updates from The Motley Fool

Latest updates on AbbVie from Fool.com.  The Fool has written over 500 articles on AbbVie.
3 Dividend Healthcare Stocks

On the hunt for income? Here's why our team of healthcare experts thinks you should check out Abb...

3 Value Stocks for Wise Investors

Looking for value in today's pricey market? Here's why our team thinks you should check out Ampli...

3 Dividend Stock Winners

Looking for great dividend stocks that should be long-term winners? Check out General Motors, Enb...



Stock Performance

View Interactive ABBV Charts
Sponsored by

Key Data Points

Primary metrics and data points about AbbVie.
Current Price: $70.12
Prev Close: $69.96
Open: $69.92
Bid: $70.09
Ask: $70.11
Day's Range: $69.91 - $70.39
52wk Range: $55.06 - $75.04
Volume: 233,336
Avg Vol 4,884,799
Market Cap: $112B
P/E (ttm): 13.30
EPS (ttm): $5.26
Div & Yield: $2.56 (3.7%)

Company Rating

What our community thinks about AbbVie.
CAPS Rating 4 out of 5
 
409 Outperform
10 Underperform
CAPS All Stars
 
85 Outperform
4 Underperform

How do you think AbbVie will perform against the market?



You pick for AbbVie is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Richard A. Gonzalez, CEO

86% Approve

Based on 277 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for AbbVie.

AbbVie Inc.

  • Exchange: NYSE